Subject(s)

Coronary Aneurysm , Mucocutaneous Lymph Node Syndrome , Coronary Aneurysm/diagnostic imaging , Coronary Aneurysm/drug therapy , Coronary Aneurysm/etiology , Cyclophosphamide/therapeutic use , Humans , Immunoglobulins, Intravenous , Mucocutaneous Lymph Node Syndrome/complications , Mucocutaneous Lymph Node Syndrome/drug therapy , Risk Factors